Venous thromboembolism (VTE) risk stratification in general medical patients at an academic medical center

被引:0
|
作者
Megan Kunka Fritz
Scott E. Kincaid
Charles G. Sargent
Amanda H. Green
George A. Davis
机构
[1] University of Kentucky HealthCare,Pharmacy Department
[2] University of Kentucky HealthCare,Division of Hospital Medicine
[3] University of Kentucky HealthCare,Department of Nursing
[4] University of Kentucky HealthCare,Pharmacy Department
来源
关键词
Venous thromboembolism; Classification; Risk factors; Low molecular weight heparin; Heparin;
D O I
暂无
中图分类号
学科分类号
摘要
Hospital-acquired venous thromboembolism (VTE) is still a concern for general medical patients. Pharmacologic prophylaxis can reduce VTE incidence, but there is the potential for adverse effects. Therefore, determining which patients should receive VTE prophylaxis via risk scoring tools is essential. Limited evidence exists for the ideal venous thromboembolism risk assessment model (RAM) in hospitalized medical patients, as compared to other hospitalized patient subgroups such as surgical patients. The primary objective was to investigate the utilization and appropriateness of our institution-based VTE RAM and comparison to the Padua Prediction Score (PPS). This would allow for a gauge of provider risk assessment accuracy as well as appropriate predictive potential of the PPS or whether an alternative to the PPS should be considered. A total of 330 adult general medicine patients were included in this retrospective chart review. When compared to our institution-based VTE RAM, providers predominately stratified patients at a higher VTE risk than the institution-based VTE RAM. VTE incidence was 0.3%, which was lower than predicted. Significant discordance exists between providers’ VTE risk assessment and that predicted by RAMs. Our institution-based VTE RAM appears comparable to PPS; however, it was not being utilized by providers, resulting in potentially unnecessary use of pharmacologic prophylaxis. The most appropriate venous thromboembolism risk assessment model for general medicine patients is undetermined.Our providers generally assess patients as moderate or high VTE risk, despite our institution-based RAM which typically recommends a lower risk category than provider selection.Because of provider risk assessment, more patients received pharmacologic VTE prophylaxis than would have been recommended by the RAM, which might correlate to the low incidence of VTE which was < 0.5%, although bleeding complications were not assessed in this study.A prospective study utilizing the Padua Prediction Score (or similar RAM) in general medicine patients is warranted in order to decipher the best method of predicting VTE risk.
引用
下载
收藏
页码:67 / 73
页数:6
相关论文
共 50 条
  • [41] Preventing venous thromboembolism in medical patients
    Leizorovicz, A
    Mismetti, P
    CIRCULATION, 2004, 110 (24) : 13 - 19
  • [42] Prophylaxis of venous thromboembolism in medical patients
    Gerotziafas, GT
    Samama, MM
    CURRENT OPINION IN PULMONARY MEDICINE, 2004, 10 (05) : 356 - 365
  • [43] Venous thromboembolism prophylaxis in medical patients
    Goldhaber, SZ
    THROMBOSIS AND HAEMOSTASIS, 1999, 82 (02) : 899 - 901
  • [44] Venous thromboembolism prophylaxis in medical patients
    Michota, FA
    CURRENT OPINION IN CARDIOLOGY, 2004, 19 (06) : 570 - 574
  • [45] Low persistence to rivaroxaban or warfarin among patients with new venous thromboembolism at a safety net academic medical center
    Sweta Meet Patel
    Tina Wang
    Desire Lashalle Outler
    Jennifer Elliott
    Michael Knauss
    Samuel K. Peasah
    Mikhail Akbashev
    Journal of Thrombosis and Thrombolysis, 2020, 49 : 287 - 293
  • [46] Low persistence to rivaroxaban or warfarin among patients with new venous thromboembolism at a safety net academic medical center
    Patel, Sweta Meet
    Wang, Tina
    Outler, Desire Lashalle
    Elliott, Jennifer
    Knauss, Michael
    Peasah, Samuel K.
    Akbashev, Mikhail
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 49 (02) : 287 - 293
  • [47] Venous thromboembolism (VTE) risk factors
    Lutsey, P. L.
    Virnig, B. A.
    Steffen, L. M.
    Jacobs, D. R., Jr.
    Folsom, A. R.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2008, 167 (11) : S67 - S67
  • [48] Risk stratification for hospital-acquired venous thromboembolism in medical patients (RISE): Protocol for a prospective cohort study
    Choffat, Damien
    Farhoumand, Pauline Darbellay
    Jaccard, Evrim
    de la Harpe, Roxane
    Kraege, Vanessa
    Benmachiche, Malik
    Gerber, Christel
    Leuzinger, Salome
    Podmore, Clara
    Truong, Minh Khoa
    Dumans-Louis, Celine
    Marti, Christophe
    Reny, Jean-Luc
    Aujesky, Drahomir
    Rakovic, Damiana
    Limacher, Andreas
    Rossel, Jean-Benoit
    Baumgartner, Christine
    Mean, Marie
    PLOS ONE, 2022, 17 (05):
  • [49] Venous thromboembolism (VTE) risk assessment in cancer patients receiving chemotherapy in a tertiary care center
    Varghese, Smita
    Pai, Radhika R.
    DSouza, Janet Prameela
    Badagabettu, Sulochana
    Udupa, Karthik S.
    Pai, Anantha
    JOURNAL OF VASCULAR NURSING, 2022, 40 (04) : 167 - 171
  • [50] Venous thromboembolism validation study of the improve risk assessment models in the medical patient (VTE-VALOURR)
    Mahan, C.
    Liu, Y.
    Douketis, J. D.
    Turpie, A. G. G.
    Spyropoulos, A. C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 402 - 403